Stefan Henke IIS Innovative Injektions-Systeme GmbH & Co.KG

Dr. Stefan Henke has been Managing Director of IIS Innovative Injektions-Systeme GmbH & Co.KG, Andernach since 2010. IIS is a 100% subsidiary of Lohmann Therapie-Systeme AG. IIS develops parenteral and sterile transdermal technology platforms (Needle-free Injection Systems and Microneedles) for use of biologicals, pharmaceuticals and vaccines. Dr. Henke studied pharmacy and completed his PhD. thesis at Philipps University of Marburg. He started his career as Scientist Oral dosage forms at Schering AG, Berlin (1992-1996). From 1996 until 2002, he was responsible for Pharmaceutical Development of Boehringer Ingelheim Vetmedica GmbH, Ingelheim. From 2002 to 2008, he was in charge of the Research and Development international/national as Director of Merck Selbstmedikation GmbH, Darmstadt. From 2008 to 2010, he was Managing Director of Merz Consumer Care GmbH, Frankfurt.